rs374142395
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BS2
The NM_001903.5(CTNNA1):c.410G>A(p.Arg137Gln) variant causes a missense change. The variant allele was found at a frequency of 0.0000239 in 1,461,876 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R137W) has been classified as Likely benign.
Frequency
Consequence
NM_001903.5 missense
Scores
Clinical Significance
Conservation
Publications
- CTNNA1-related diffuse gastric and lobular breast cancer syndromeInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- patterned macular dystrophy 2Inheritance: AD Classification: DEFINITIVE, STRONG, LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
- patterned macular dystrophyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hereditary nonpolyposis colon cancerInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CTNNA1 | NM_001903.5 | c.410G>A | p.Arg137Gln | missense_variant | Exon 4 of 18 | ENST00000302763.12 | NP_001894.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CTNNA1 | ENST00000302763.12 | c.410G>A | p.Arg137Gln | missense_variant | Exon 4 of 18 | 1 | NM_001903.5 | ENSP00000304669.7 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.0000199 AC: 5AN: 251492 AF XY: 0.0000147 show subpopulations
GnomAD4 exome AF: 0.0000239 AC: 35AN: 1461876Hom.: 0 Cov.: 30 AF XY: 0.0000261 AC XY: 19AN XY: 727240 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Uncertain:2
This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 137 of the CTNNA1 protein (p.Arg137Gln). This variant is present in population databases (rs374142395, gnomAD 0.006%). This variant has not been reported in the literature in individuals affected with CTNNA1-related conditions. ClinVar contains an entry for this variant (Variation ID: 409007). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt CTNNA1 protein function with a positive predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Observed in 18/151425 individuals who underwent multigene panel testing (Clark et al., 2020); This variant is associated with the following publications: (PMID: 32051609)
Hereditary cancer-predisposing syndrome Uncertain:1
The p.R137Q variant (also known as c.410G>A), located in coding exon 3 of the CTNNA1 gene, results from a G to A substitution at nucleotide position 410. The arginine at codon 137 is replaced by glutamine, an amino acid with highly similar properties. This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Based on the available evidence, the clinical significance of this variant remains unclear.
Patterned macular dystrophy 2 Uncertain:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at